|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2004-6-4
|
|
pubmed:abstractText |
The effect of dicarbamin on the hemopoetic cells of the bone marrow of ovarian cancer patients receiving myelosuppressive combination chemotherapy (cyclophosphamide + carboplatin) is discussed.
|
|
pubmed:language |
rus
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0507-3758
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
50
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
188-95
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15176222-Adult,
pubmed-meshheading:15176222-Aged,
pubmed-meshheading:15176222-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:15176222-Bone Marrow Cells,
pubmed-meshheading:15176222-Carboplatin,
pubmed-meshheading:15176222-Cyclophosphamide,
pubmed-meshheading:15176222-Drug Administration Schedule,
pubmed-meshheading:15176222-Female,
pubmed-meshheading:15176222-Hematologic Diseases,
pubmed-meshheading:15176222-Hematopoiesis,
pubmed-meshheading:15176222-Humans,
pubmed-meshheading:15176222-Imidazoles,
pubmed-meshheading:15176222-Middle Aged,
pubmed-meshheading:15176222-Ovarian Neoplasms,
pubmed-meshheading:15176222-Treatment Outcome
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
[The hemoprotective effect of Dicarbamin in ovarian cancer patients receiving chemotherapy].
|
|
pubmed:affiliation |
N.N. Blokhin Center for Oncology Research, Russian Academy of Medical Sciences, Moscow.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Controlled Clinical Trial
|
